Urinary oxalate and glycolate excretion and plasma oxalate concentration
- PMID: 2031609
- PMCID: PMC1792981
- DOI: 10.1136/adc.66.4.501
Urinary oxalate and glycolate excretion and plasma oxalate concentration
Abstract
The diagnosis of primary hyperoxaluria in young children is hampered by the lack of a reliable reference range for urinary oxalate excretion, especially in infants. We present data on urinary oxalate and glycolate excretion in 137 normal children, on the plasma oxalate concentration in 33 normal children and 53 with chronic renal failure, and on amniotic fluid oxalate concentration in 63 uncomplicated pregnancies. The urinary oxalate:creatinine molar ratios were log normally distributed: mean (range) values were less than 1 year 0.061 (0.015-0.26), 1-5 years 0.036 (0.011-0.12), 5-12 years 0.030 (0.0059-0.15), and greater than 12 years 0.013 (0.0021-0.083). Geometric mean (range) plasma oxalate concentration in the normal children was 1.53 (0.78-3.02) mumols/l and was independent of age. The mean (SD) plasma oxalate: creatinine molar ratio in these normal children and 50 with chronic renal failure was 0.033 (0.013), and was independent of age and renal function. Mean (SD) amniotic fluid oxalate concentration was 19.0 (4.3) mumols/l.
Similar articles
-
Urinary oxalate and glycolate excretion in healthy infants and children.Pediatr Nephrol. 1990 Sep;4(5):493-7. doi: 10.1007/BF00869828. Pediatr Nephrol. 1990. PMID: 2242313
-
Urinary oxalate and glycolate excretion patterns in the first year of life: a longitudinal study.J Pediatr. 1993 Aug;123(2):248-51. doi: 10.1016/s0022-3476(05)81696-8. J Pediatr. 1993. PMID: 8345420
-
The quantitation of oxalate in amniotic fluid by ion-chromatography.Clin Chim Acta. 1989 Nov;185(2):131-7. doi: 10.1016/0009-8981(89)90035-1. Clin Chim Acta. 1989. PMID: 2624994
-
Plasma and urine measurements for monitoring of treatment in the primary hyperoxaluric patient.Nephrol Dial Transplant. 1995;10 Suppl 8:8-10. doi: 10.1093/ndt/10.supp8.8. Nephrol Dial Transplant. 1995. PMID: 8592630 Review.
-
Improving Treatment Options for Primary Hyperoxaluria.Drugs. 2022 Jul;82(10):1077-1094. doi: 10.1007/s40265-022-01735-x. Epub 2022 Jul 2. Drugs. 2022. PMID: 35779234 Free PMC article. Review.
Cited by
-
Urinary oxalate excretion in urolithiasis and nephrocalcinosis.Arch Dis Child. 2000 Apr;82(4):322-6. doi: 10.1136/adc.82.4.322. Arch Dis Child. 2000. PMID: 10735843 Free PMC article.
-
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial.Front Pediatr. 2024 Sep 16;12:1392644. doi: 10.3389/fped.2024.1392644. eCollection 2024. Front Pediatr. 2024. PMID: 39355649 Free PMC article.
-
Hereditary causes of kidney stones and chronic kidney disease.Pediatr Nephrol. 2013 Oct;28(10):1923-42. doi: 10.1007/s00467-012-2329-z. Epub 2013 Jan 20. Pediatr Nephrol. 2013. PMID: 23334384 Free PMC article. Review.
-
Urolithiasis in the first year of life.Pediatr Nephrol. 2010 Jan;25(1):129-34. doi: 10.1007/s00467-009-1296-5. Pediatr Nephrol. 2010. PMID: 19705157
-
Neonatal transient renal failure with renal medullary hyperechogenicity: clinical and laboratory features.Pediatr Nephrol. 2005 Jul;20(7):904-9. doi: 10.1007/s00467-005-1868-y. Epub 2005 May 7. Pediatr Nephrol. 2005. PMID: 15880271 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources